CDC Eases Indoor Mask-Wearing Guidance for Fully Vaccinated Individuals
The CDC today announced an updated guidance on mask wearing and social distancing for individuals fully vaccinated against COVID-19.
US Supreme Court Hears Argument on State’s Ability to Regulate PBMs
Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.
Walmart Sues DOJ, DEA to Clarify Pharmacists’ Role in Filling Opioid Prescriptions
Walmart filed a pre-emptive suit against 2 government agencies that are threatening to sue Walmart over its pharmacists filling opioid prescriptions.
US Supreme Court Proceeds With Hearing on Landmark PBM Regulation Case
Rutledge v. Pharmaceutical Care Management Association seeks to clarify whether states can regulate pharmacy benefit managers.
FDA Approves CBD Treatment for Seizures in Rare Genetic Disease
The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.
FDA Releases Guidance To Boost Cannabis Clinical Research
Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.
